Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine (Q40182562)

18 September 2017

Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine (English)

1 reference

18 September 2017

0 references

0 references

Devorah Matas

1

1 reference

18 September 2017

Ana Juknat

2

1 reference

18 September 2017

Maciej Pietr

3

1 reference

18 September 2017

Yael Klin

4

1 reference

18 September 2017

Zvi Vogel

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

16 January 2007

1 reference

Journal of Biological Chemistry

18 September 2017

1 reference

18 September 2017

282

1 reference

18 September 2017

11

1 reference

18 September 2017

7885-7892

1 reference

The endocannabinoid system and its therapeutic exploitation

18 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Involvement of cannabinoids in cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Cannabinoids: potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Cannabinoids and neuroprotection in CNS inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

(-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Modulation of anxiety through blockade of anandamide hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

N-methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Ethanolamine analogues stimulate DNA synthesis by a mechanism not involving phosphatidylethanolamine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Survival factor-insensitive generation of reactive oxygen species induced by serum deprivation in neuronal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Cannabinoids: between neuroprotection and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Anandamide and other N-acylethanolamines in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Possible endocannabinoid control of colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Studies of human tumors by MRS: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Phospholipid metabolites as indicators of cancer cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Extracellular sphingosine 1-phosphate stimulates formation of ethanolamine from phosphatidylethanolamine: modulation of sphingosine 1-phosphate-induced mitogenesis by ethanolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Phosphorylation of ethanolamine, methylethanolamine, and dimethylethanolamine by overexpressed ethanolamine kinase in NIH 3T3 cells decreases the co-mitogenic effects of ethanolamines and promotes cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

Ethanolamine, but not phosphoethanolamine, potentiates the effects of insulin, phosphocholine, and ATP on DNA synthesis in NIH 3T3 cells--role of mitogen-activated protein-kinase-dependent and protein-kinase-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M608646200

21 January 2018

Identifiers

DOI

10.1074/JBC.M608646200

1 reference

release_wvawbr4ljjapllnhp4yyw4yzee

18 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wvawbr4ljjapllnhp4yyw4yzee

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference